NIPER, Hindustan Antibiotic sign MoU for developing 3D antimicrobial face-shields
NIPER-Guwahati has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields;
New Delhi: National Institute of Pharmaceuticals Education and Research (NIPER)-Guwahati, a premier Institute of National Importance under the Department of Pharmaceuticals, Union Ministry of Chemicals and Fertilizers, Govt. of India is committed to providing a useful contribution cum solution in terms of developing Personal Protective Equipment's (PPEs) to avoid the fatal spread of COVID-19 transmission.
Director Dr. U S N. Murty informed that he signed MoU with the Hindustan Antibiotic Limited (HAL, a PSU under Dept. of Pharmaceuticals, Govt. of India), Pimpri, Pune for large scale industrial-grade manufacturing and commercialization of their 3D printed antimicrobial face-shields.
NIPER-Guwahati has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.